Alimera Sciences reported $49.93M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Abbvie ABBV:US $ 143211M 3318M
Aerie Pharmaceuticals AERI:US $ 395.55M 35.84M
Alimera Sciences ALIM:US $ 49.93M 8.59M
Applied Genetic Technologies AGTC:US $ 87.19M 5.18M
Bayer BAYN:GR € 125782M 5541M
Insmed INSM:US $ 1.15B 90.19M
Novartis NOVN:VX SF 125218M 6577M
Ophthotech OPHT:US $ 352.7M 36.65M
Regeneron Pharmaceuticals REGN:US $ 26348.7M 913.9M